Recovery & Healing Research Peptides

Recovery peptides are the most widely researched category in the practitioner and sports research communities. BPC-157, TB-500, and GHK-Cu in particular have extensive preclinical literature demonstrating accelerated healing across multiple tissue types. QSC supplies the full recovery peptide spectrum at ≥99% HPLC purity.

BPC-157 (Body Protection Compound)

CAS 137525-51-0 · MW 1419.53 Da · 15-residue gastric pentadecapeptide

BPC-157 is derived from a protein sequence found in human gastric juice and is remarkable for its stability in gastric acid — an unusual property that has made it a subject of sustained research interest. Its multi-pathway mechanism (NO modulation, VEGF upregulation, FAK-paxillin signalling) translates into a broad range of preclinical tissue repair effects: tendon, ligament, muscle, bone, gut mucosa, and peripheral nerve repair have all been studied in rodent models. It is a component of both the Clavicular Ascension Stack and the Venus Protocol. See the full BPC-157 research guide.

TB-500 (Thymosin Beta-4 Fragment)

CAS 107761-42-2 · MW 5013.0 Da · Thymosin Beta-4 active fragment

TB-500 is the synthetic form of the active fragment of Thymosin Beta-4 (Ac-LKKTETQ), an actin-sequestering protein involved in cell migration and wound repair. Unlike BPC-157 which acts primarily through growth factor pathways, TB-500 promotes healing through actin polymerisation dynamics that facilitate cell motility and migration to injury sites. Its longer half-life (days vs hours for BPC-157) makes it suitable for less frequent dosing protocols. Many researchers use BPC-157 and TB-500 simultaneously for complementary tissue repair coverage.

Recovery Peptide Comparison